Here’s a short interview from Becker’s ASC Review. #GITwitter #GIFellowship #GIFamily @AmCollegeGastro @AmerGastroAssn @ASGEendoscopy Click here for the interview.
A retrospective study of three large health systems found that the risk for colorectal cancer following a colonoscopy was lower when the colonoscopy was conducted by a physician with higher adenoma detection rates (ADR’s). Adenomas are the usual precursor type polyps that can lead to colon cancer. At the Endoscopy Center of the North Shore,
The American Gastroenterological Association has released a new Clinical Practice Update providing best practice advice on how to approach de-prescribing proton pump inhibitors (PPI) in ambulatory patients. See the AGA website information here.
Dr. Lisa Strate from the University of Washington discusses this difficult topic in the attached video. At ACG 2018, Dr. Strate described the various presentations of symptomatic diverticular disease and reviewed current therapeutic approaches. See the video at the ACG Universe here.
From the New York Times, a striking editorial suggests for the first time something that healthcare workers have long known firsthand–that if there is any flexibility in the healthcare system, it falls squarely on the shoulders of the people providing care. As author Danielle Ofri, MD, PhD states, “the one resource that seems endless —
We understand that the microbiome has emerged as an important consideration in clinical science, and this includes extension into the important world of oncology. The role of the microbiome in cancer is not just limited to causation and cancer risk. We now known that the microbiome modifies immune responses to tumors. It influences the clinical
As a new pet owner (meet Jaxon!) I immediately noticed how much “overlap” there is with dog life and my life. Licks, kisses, and paws on you that have been…God knows where. And while I wouldn’t trade it for the world, the infectious-conscious doctor in me wonders if this is a good thing or bad
MedPage Today reports two interesting pieces of reporting simultaneously this week. First, Public Citizen published a report showing from 1991 through 2017, a total of 412 legal settlements were reached between the federal and state governments and pharmaceutical manufacturers. The fines, settlements, and fees comprised a whopping total of $38.6 billion. For 2016 and 2017, 38 settlements